{"schema_version":"secwatch.filing_event.v1","accession":"0001746473-25-000159","form_type":"8-K","ticker":"PLRX","cik":"0001746473","company_name":"PLIANT THERAPEUTICS, INC.","filed_at":"2025-10-24T23:59:59+00:00","discovered_at":"2026-05-14T18:02:40.328420+00:00","generated_at":"2026-05-17T02:21:07.306825+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.35,"calibrated_materiality_score":0.35,"confidence":"high","headline":"Pliant Therapeutics CBO Hans Hull resigns effective October 20, 2025","bullets":["Hans Hull resigned as Chief Business Officer, effective October 20, 2025.","Resignation was not due to any disagreement on operations, policies, or practices.","No replacement has been announced as of the filing date."],"urls":{"canonical":"https://secwatch.observer/filing/0001746473-25-000159","json":"https://secwatch.observer/filing/0001746473-25-000159.json","markdown":"https://secwatch.observer/filing/0001746473-25-000159.md","text":"https://secwatch.observer/filing/0001746473-25-000159.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/0001746473-25-000159-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1746473/000174647325000159/plrx-20251020.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T02:21:07.306825+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}